|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/198 | (2006.01) |
| A61K 31/519 | (2006.01) | ||
| C07D 487/04 | (2006.01) |
| (11) | Number of the document | 2497470 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12158715.8 |
| Date of filing the European patent application | 2007-11-19 | |
| (97) | Date of publication of the European application | 2012-09-12 |
| (45) | Date of publication and mention of the grant of the patent | 2015-10-28 |
| (46) | Date of publication of the claims translation | 2016-02-10 |
| (30) | Number | Date | Country code |
| 860840 P | 2006-11-22 | US | |
| 861459 P | 2006-11-29 | US | |
| 957236 P | 2007-08-22 | US |
| (72) |
Zhuo, Jincong, US
Metcalf, Brian, US
Xu, Meizhong, US
He, Chunhong, US
Zhang, Colin, US
Qian, Ding-quan, US
Burns, David M., US
Li, Yunlong, US
Yao, Wenqing, US
|
| (73) |
Incyte Holdings Corporation,
1801 Augustine Cut-Off, Wilmington, DE 19803,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Imidazotriazinai ir imidazopirimidinai kaip kinazės inhibitoriai |
| Imidazotriazines and imidazopyrimidines as kinase inhibitors |
| Payment date | Validity (years) | Amount | |
| 2024-11-06 | 18 | 347.00 EUR |
| 2025-11-19 |